DeuterOncology NV
Biotechnology Research
Liège Walloon Region, Be
4 employees
- Employees
- 4
- Contacts
- 1
- Emails
- 1
DeuterOncology NV Overview
- Headquarters
- Liège Walloon Region, Be
- Website
- www.deuteroncology.com
- Industry
- Biotechnology Research
- Employees
- 4
- Founded
- 2020
- Funding
- 6.1M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About DeuterOncology NV
DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2.
DeuterOncology NV Contact Details
- People in AeroLeads
- 2
- With contact data
- 1
- Email contacts
- 1
- 50.0% coverage
DeuterOncology NV Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Carol Walton, Phd | Biotech and Investor Consultant |
View
|
|
| Hilde Windels | Life Sciences Advisor and Board Member | Ghent, Flemish Region, Belgium |
Email
|
Compare Similar Companies to DeuterOncology NV
Hyloris Pharmaceuticals
Biotechnology Research
Estetra
Pharmaceutical Manufacturing
Celyad Oncology
Biotechnology Research
EXO Biologics
Biotechnology
THERAtRAME
Biotechnology
convEyXO
Biotechnology Research
EsoBiotec
Biotechnology Research
ABSCINT
Biotechnology Research
Amyl Therapeutics
Biotechnology Research
InhaTarget Therapeutics
Pharmaceutical Manufacturing